RZLT
Rezolute, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.58
+0.88%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 90.67x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.77x
- Price / sales
- —
- Price / cash flow
- -6.00x
Enterprise value
- Enterprise value
- $321.9M
- EV / sales
- —
- EV / EBITDA
- -3.95x
- EV / EBIT
- -3.69x
- Market cap
- $441.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026